Abstract:Many recent studies have shown that flagellin fused to heterologous antigens can induce significantly enhanced humoral and cellular immune responses through its adjuvant activity. Therefore, in this study, two key B cell epitopes and a truncated VP1 (ΔVP1) protein from foot-and-mouth disease virus (FMDV) were expressed as flagellin fusion proteins in different patterns. Specifically, ΔVP1 and two duplicates of two key B cell epitopes (2×B1B2) were fused separately to the C-terminus of flagellin with a universal exogenous T cell epitope to construct FT (Flagellin-Truncated VP1) and FME (Flagellin-Multiple Epitopes). In addition, the D3 domain of flagellin was replaced by ΔVP1 in FME, yielding FTME (Flagellin-Truncated VP1-Multiple Epitopes). The immunogenicity and protective efficacy of the three fusion proteins as novel FMDV vaccine candidates were evaluated. The results showed that FT, FME, and FTME elicited significant FMDV-specific IgG responses at 10 μg/dose compared with the mock group (P < 0.05), with FTME producing the highest response. No significant differences in the antibody response to FTME were observed between different immunization routes or among adjuvants (ISA-206, poly(I·C), MPLA, and CpG-ODN) in mice. In addition, at 30 μg/dose, all three fusion proteins significantly induced neutralizing antibody production and upregulated the levels of some cytokines, including TNF-α, IFN-γ, and IL-12, in guinea pigs. Importantly, all three fusion proteins provided effective protective immunity against FMDV challenge in guinea pigs, though different protection rates were found. The results presented in this study indicate that the FTME fusion protein is a promising novel vaccine candidate for the future prevention and control of foot-and-mouth disease.

A Novel Mucosal Vaccine Against Foot-and-Mouth Disease Virus Induces Protection in Mice and Swine

Poly(I:C) Combined with Multi-Epitope Protein Vaccine Completely Protects Against Virulent Foot-and-mouth Disease Virus Challenge in Pigs

Enhancement of Serological Immune Responses to Foot-And-Mouth Disease Vaccine by A Supplement Made of Extract of Cochinchina Momordica Seeds

High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha.

Improved neutralising antibody response against foot-and-mouth-disease virus in mice inoculated with a multi-epitope peptide vaccine using polyinosinic and poly-cytidylic acid as an adjuvant.

Protection of Guinea Pigs and Swine by a Recombinant Adenovirus Expressing O Serotype of Foot-and-mouth Disease Virus Whole Capsid and 3C Protease.

Immunization of DNA Vaccine Encoding C3d-VP1 Fusion Enhanced Protective Immune Response Against Foot-and-mouth Disease Virus

Protection of a Novel Epitope-Rna VLP Double-Effective VLP Vaccine for Foot-and-mouth Disease.

Heterologous Expression of FMDV Immunodominant Epitopes and HSP70 in P. Pastoris and the Subsequent Immune Response in Mice

[Fusion Expression of O Type Foot-and-mouth Diseases Virus VP1 Gene and HSP70 Gene and Induction of Immune Responses in Mice].

Protective Immune Responses Against Foot-And-Mouth Disease Virus by Vaccination with A Dna Vaccine Expressing Virus-Like Particles

Vaccination of pigs against foot-and-mouth disease virus with a DNA vaccine containing VP1 gene using Lactobacillus acidophilus as carrier

Potent immune responses against thermostable Foot-and-Mouth disease virus VP1 nanovaccine adjuvanted with polymeric thermostable scaffold

Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon α in mice and protective efficacy in guinea pigs and swine

Influence of FMDV epitopes-hsp70 fusion protein on immune responses in mice

Evaluation of Cross-Protection Against Three Topotypes of Serotype O Foot-and-mouth Disease Virus in Pigs Vaccinated with Multi-Epitope Protein Vaccine Incorporated with Poly(i:C)

Enhancement of Mouse Immune Response by Recombinant Adenovirus Co-Expressing VP1-2A of Foot-and-mouth Disease Virus and Porcine IFN-α

The immune response to a recombinant Lactococcus lactis oral vaccine against foot-and-mouth disease virus in mice

Construction of Genetically Engineered Vaccine Candidate of Type O Foot-and-Mouth-Disease Virus of Pig and Analysis of Its Immunogenicity

Expression and immunogenicity of capsid protein of porcine circovirus type 2 with N-terminal chimeric neutralizing epitopes of foot-and-mouth disease virus

Immunogenicity and protective efficacy of recombinant proteins consisting of multiple epitopes of foot-and-mouth disease virus fused with flagellin